Immunogen Inc logo

Immunogen Inc

NAS:IMGN (USA)  
$ 14.56 -0.075 (-0.51%) 10:21 AM EST
P/E:
At Loss
P/B:
7.39
Market Cap:
$ 3.62B
Enterprise V:
$ 3.16B
Volume:
668.15K
Avg Vol (2M):
4.55M
Also Trade In:
Volume:
668.15K
Market Cap $:
3.62B
PE Ratio:
At Loss
Avg Vol (2M):
4.55M
Enterprise Value $:
3.16B
PB Ratio:
7.39

Business Description

Description
Immunogen Inc is a clinical-stage biotechnology company from the United States. Its focus is antibody-drug conjugate, or ADC, technology, which uses an antibody that fixes on a target (its antigen) found on tumor cells to deliver a specific cancer-killing agent.
Name Current Vs Industry Vs History
Cash-To-Debt 6.71
Equity-to-Asset 0.69
Debt-to-Equity 0.17
Debt-to-EBITDA -0.5
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 7.56
Distress
Grey
Safe
Beneish M-Score 4.1
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 14.83
9-Day RSI 27.4
14-Day RSI 34.77
6-1 Month Momentum % 297.96
12-1 Month Momentum % 210.32

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.14
Quick Ratio 7.11
Cash Ratio 6.1
Days Inventory 410.33
Days Sales Outstanding 44.77
Days Payable 5694.81

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -14.6
Shareholder Yield % -0.31

Financials (Next Earnings Date:2023-11-03 Est.)

IMGN's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:IMGN

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Immunogen Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 189.564
EPS (TTM) ($) -0.72
Beta 0.33
Volatility % 166.28
14-Day RSI 34.77
14-Day ATR ($) 0.639384
20-Day SMA ($) 15.69525
12-1 Month Momentum % 210.32
52-Week Range ($) 3.605 - 20.69
Shares Outstanding (Mil) 248.94

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Immunogen Inc Filings

Filing Date Document Date Form
No Filing Data

Immunogen Inc Stock Events

Event Date Price($)
No Event Data

Immunogen Inc Frequently Asked Questions

What is Immunogen Inc(IMGN)'s stock price today?
The current price of IMGN is $14.56. The 52 week high of IMGN is $20.69 and 52 week low is $3.61.
When is next earnings date of Immunogen Inc(IMGN)?
The next earnings date of Immunogen Inc(IMGN) is 2023-11-03 Est..
Does Immunogen Inc(IMGN) pay dividends? If so, how much?
Immunogen Inc(IMGN) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1